The changing pattern of posttransplant malignancies.
Penn
I
I
University of Cincinnati Medical Center, Department of Surgery, OH 45267-0558.
D000375:Aging; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D003524:Cyclosporins / Q000627:therapeutic use; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation / Q000009:adverse effects; D008228:Lymphoma, Non-Hodgkin / Q000209:etiology; D016853:Muromonab-CD3; D009369:Neoplasms / Q000209:etiology*; D016377:Organ Transplantation / Q000009:adverse effects*; D012514:Sarcoma, Kaposi / Q000209:etiology
D000911:Antibodies, Monoclonal; D003524:Cyclosporins; D016853:Muromonab-CD3